Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence

Substantial evidence suggests that people with type 2 diabetes have an increased risk of developing several types of cancers. These associations may be due to a number of direct and indirect mechanisms. Observational studies of these associations, including the potential role for glucose-lowering th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetologia 2012-06, Vol.55 (6), p.1607-1618
Hauptverfasser: Johnson, J. A., Carstensen, B., Witte, D., Bowker, S. L., Lipscombe, L., Renehan, A. G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1618
container_issue 6
container_start_page 1607
container_title Diabetologia
container_volume 55
creator Johnson, J. A.
Carstensen, B.
Witte, D.
Bowker, S. L.
Lipscombe, L.
Renehan, A. G.
description Substantial evidence suggests that people with type 2 diabetes have an increased risk of developing several types of cancers. These associations may be due to a number of direct and indirect mechanisms. Observational studies of these associations, including the potential role for glucose-lowering therapy, are being increasingly reported, but face a number of methodological challenges. This paper is the first of two review papers addressing methodological aspects underpinning the interpretations of links between diabetes and cancer, and suggests potential approaches to study designs to be considered in observational studies. This paper reviews factors related to cancer incidence in the diabetic population; the second paper relates to studies of cancer mortality.
doi_str_mv 10.1007/s00125-012-2525-1
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_537942</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2660393511</sourcerecordid><originalsourceid>FETCH-LOGICAL-c483t-58c08016d6f1fe3630a60da8fe2f3f02f12c87228551fe42c6f066c9d6e242ef3</originalsourceid><addsrcrecordid>eNp1kU1vFDEMhiMEotuFH8AFRUJI5TDgOB-T5YZK-ZAqcQGJW5TNOO0sszNDMkPVf09WOxSE4OJY9mPH9svYEwEvBUD9KgMI1FUxFeriiHtsJZTEChTa-2x1SFfCmq8n7DTnHQBIrcxDdoKoarNR9Yrt3rZ-SxNl7vuGB98HSvxMvHjN6YfvZj-1_RWfrolPtB-H5DueqCvRoc_X7chL6Q1Rz6fbkTjy5h_N2j60DRX3EXsQfZfp8fKu2Zd3F5_PP1SXn95_PH9zWQVl5VRpG8CCMI2JIpI0EryBxttIGGUEjAKDrRGt1iWvMJgIxoRNYwgVUpRrVh375hsa560bU7v36dYNvnVL6FvxyGlZbxQW_uzIj2n4PlOe3L7NgbrO9zTM2QlAsFjbctk1e_YXuhvm1JdtCiWkMkqCLpQ4UiENOSeKdyMIcAfh3FE4V4w7COdEqXm6dJ63e2ruKn4pVYDnC-Bz8F1M5bpt_s1pa2sjD9vgsn1J9VeU_hzxf7__BCunryk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1013464305</pqid></control><display><type>article</type><title>Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Johnson, J. A. ; Carstensen, B. ; Witte, D. ; Bowker, S. L. ; Lipscombe, L. ; Renehan, A. G.</creator><creatorcontrib>Johnson, J. A. ; Carstensen, B. ; Witte, D. ; Bowker, S. L. ; Lipscombe, L. ; Renehan, A. G. ; Diabetes and Cancer Research Consortium ; on behalf of the Diabetes and Cancer Research Consortium</creatorcontrib><description>Substantial evidence suggests that people with type 2 diabetes have an increased risk of developing several types of cancers. These associations may be due to a number of direct and indirect mechanisms. Observational studies of these associations, including the potential role for glucose-lowering therapy, are being increasingly reported, but face a number of methodological challenges. This paper is the first of two review papers addressing methodological aspects underpinning the interpretations of links between diabetes and cancer, and suggests potential approaches to study designs to be considered in observational studies. This paper reviews factors related to cancer incidence in the diabetic population; the second paper relates to studies of cancer mortality.</description><identifier>ISSN: 0012-186X</identifier><identifier>EISSN: 1432-0428</identifier><identifier>DOI: 10.1007/s00125-012-2525-1</identifier><identifier>PMID: 22476947</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Biological and medical sciences ; Cancer research ; Cohort analysis ; Consortia ; Design ; Diabetes ; Diabetes Mellitus, Type 2 - complications ; Diabetes Mellitus, Type 2 - epidemiology ; Diabetes. Impaired glucose tolerance ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Epidemiology ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Glucose ; Human Physiology ; Humans ; Internal Medicine ; Kinases ; Medical research ; Medical sciences ; Medicine ; Medicine &amp; Public Health ; Metabolic Diseases ; Neoplasms - epidemiology ; Neoplasms - etiology ; Neoplasms - mortality ; Observational studies ; Ovarian cancer ; Review ; Risk Factors</subject><ispartof>Diabetologia, 2012-06, Vol.55 (6), p.1607-1618</ispartof><rights>Springer-Verlag 2012</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c483t-58c08016d6f1fe3630a60da8fe2f3f02f12c87228551fe42c6f066c9d6e242ef3</citedby><cites>FETCH-LOGICAL-c483t-58c08016d6f1fe3630a60da8fe2f3f02f12c87228551fe42c6f066c9d6e242ef3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00125-012-2525-1$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00125-012-2525-1$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25887632$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22476947$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:124570513$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Johnson, J. A.</creatorcontrib><creatorcontrib>Carstensen, B.</creatorcontrib><creatorcontrib>Witte, D.</creatorcontrib><creatorcontrib>Bowker, S. L.</creatorcontrib><creatorcontrib>Lipscombe, L.</creatorcontrib><creatorcontrib>Renehan, A. G.</creatorcontrib><creatorcontrib>Diabetes and Cancer Research Consortium</creatorcontrib><creatorcontrib>on behalf of the Diabetes and Cancer Research Consortium</creatorcontrib><title>Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence</title><title>Diabetologia</title><addtitle>Diabetologia</addtitle><addtitle>Diabetologia</addtitle><description>Substantial evidence suggests that people with type 2 diabetes have an increased risk of developing several types of cancers. These associations may be due to a number of direct and indirect mechanisms. Observational studies of these associations, including the potential role for glucose-lowering therapy, are being increasingly reported, but face a number of methodological challenges. This paper is the first of two review papers addressing methodological aspects underpinning the interpretations of links between diabetes and cancer, and suggests potential approaches to study designs to be considered in observational studies. This paper reviews factors related to cancer incidence in the diabetic population; the second paper relates to studies of cancer mortality.</description><subject>Biological and medical sciences</subject><subject>Cancer research</subject><subject>Cohort analysis</subject><subject>Consortia</subject><subject>Design</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Diabetes Mellitus, Type 2 - epidemiology</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Epidemiology</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Glucose</subject><subject>Human Physiology</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Kinases</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metabolic Diseases</subject><subject>Neoplasms - epidemiology</subject><subject>Neoplasms - etiology</subject><subject>Neoplasms - mortality</subject><subject>Observational studies</subject><subject>Ovarian cancer</subject><subject>Review</subject><subject>Risk Factors</subject><issn>0012-186X</issn><issn>1432-0428</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kU1vFDEMhiMEotuFH8AFRUJI5TDgOB-T5YZK-ZAqcQGJW5TNOO0sszNDMkPVf09WOxSE4OJY9mPH9svYEwEvBUD9KgMI1FUxFeriiHtsJZTEChTa-2x1SFfCmq8n7DTnHQBIrcxDdoKoarNR9Yrt3rZ-SxNl7vuGB98HSvxMvHjN6YfvZj-1_RWfrolPtB-H5DueqCvRoc_X7chL6Q1Rz6fbkTjy5h_N2j60DRX3EXsQfZfp8fKu2Zd3F5_PP1SXn95_PH9zWQVl5VRpG8CCMI2JIpI0EryBxttIGGUEjAKDrRGt1iWvMJgIxoRNYwgVUpRrVh375hsa560bU7v36dYNvnVL6FvxyGlZbxQW_uzIj2n4PlOe3L7NgbrO9zTM2QlAsFjbctk1e_YXuhvm1JdtCiWkMkqCLpQ4UiENOSeKdyMIcAfh3FE4V4w7COdEqXm6dJ63e2ruKn4pVYDnC-Bz8F1M5bpt_s1pa2sjD9vgsn1J9VeU_hzxf7__BCunryk</recordid><startdate>20120601</startdate><enddate>20120601</enddate><creator>Johnson, J. A.</creator><creator>Carstensen, B.</creator><creator>Witte, D.</creator><creator>Bowker, S. L.</creator><creator>Lipscombe, L.</creator><creator>Renehan, A. G.</creator><general>Springer-Verlag</general><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope></search><sort><creationdate>20120601</creationdate><title>Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence</title><author>Johnson, J. A. ; Carstensen, B. ; Witte, D. ; Bowker, S. L. ; Lipscombe, L. ; Renehan, A. G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c483t-58c08016d6f1fe3630a60da8fe2f3f02f12c87228551fe42c6f066c9d6e242ef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Biological and medical sciences</topic><topic>Cancer research</topic><topic>Cohort analysis</topic><topic>Consortia</topic><topic>Design</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Diabetes Mellitus, Type 2 - epidemiology</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Epidemiology</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Glucose</topic><topic>Human Physiology</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Kinases</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metabolic Diseases</topic><topic>Neoplasms - epidemiology</topic><topic>Neoplasms - etiology</topic><topic>Neoplasms - mortality</topic><topic>Observational studies</topic><topic>Ovarian cancer</topic><topic>Review</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Johnson, J. A.</creatorcontrib><creatorcontrib>Carstensen, B.</creatorcontrib><creatorcontrib>Witte, D.</creatorcontrib><creatorcontrib>Bowker, S. L.</creatorcontrib><creatorcontrib>Lipscombe, L.</creatorcontrib><creatorcontrib>Renehan, A. G.</creatorcontrib><creatorcontrib>Diabetes and Cancer Research Consortium</creatorcontrib><creatorcontrib>on behalf of the Diabetes and Cancer Research Consortium</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><jtitle>Diabetologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Johnson, J. A.</au><au>Carstensen, B.</au><au>Witte, D.</au><au>Bowker, S. L.</au><au>Lipscombe, L.</au><au>Renehan, A. G.</au><aucorp>Diabetes and Cancer Research Consortium</aucorp><aucorp>on behalf of the Diabetes and Cancer Research Consortium</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence</atitle><jtitle>Diabetologia</jtitle><stitle>Diabetologia</stitle><addtitle>Diabetologia</addtitle><date>2012-06-01</date><risdate>2012</risdate><volume>55</volume><issue>6</issue><spage>1607</spage><epage>1618</epage><pages>1607-1618</pages><issn>0012-186X</issn><eissn>1432-0428</eissn><abstract>Substantial evidence suggests that people with type 2 diabetes have an increased risk of developing several types of cancers. These associations may be due to a number of direct and indirect mechanisms. Observational studies of these associations, including the potential role for glucose-lowering therapy, are being increasingly reported, but face a number of methodological challenges. This paper is the first of two review papers addressing methodological aspects underpinning the interpretations of links between diabetes and cancer, and suggests potential approaches to study designs to be considered in observational studies. This paper reviews factors related to cancer incidence in the diabetic population; the second paper relates to studies of cancer mortality.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>22476947</pmid><doi>10.1007/s00125-012-2525-1</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0012-186X
ispartof Diabetologia, 2012-06, Vol.55 (6), p.1607-1618
issn 0012-186X
1432-0428
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_537942
source MEDLINE; SpringerLink Journals
subjects Biological and medical sciences
Cancer research
Cohort analysis
Consortia
Design
Diabetes
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - epidemiology
Diabetes. Impaired glucose tolerance
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Epidemiology
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Glucose
Human Physiology
Humans
Internal Medicine
Kinases
Medical research
Medical sciences
Medicine
Medicine & Public Health
Metabolic Diseases
Neoplasms - epidemiology
Neoplasms - etiology
Neoplasms - mortality
Observational studies
Ovarian cancer
Review
Risk Factors
title Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T03%3A08%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diabetes%20and%20cancer%20(1):%20evaluating%20the%20temporal%20relationship%20between%20type%202%20diabetes%20and%20cancer%20incidence&rft.jtitle=Diabetologia&rft.au=Johnson,%20J.%20A.&rft.aucorp=Diabetes%20and%20Cancer%20Research%20Consortium&rft.date=2012-06-01&rft.volume=55&rft.issue=6&rft.spage=1607&rft.epage=1618&rft.pages=1607-1618&rft.issn=0012-186X&rft.eissn=1432-0428&rft_id=info:doi/10.1007/s00125-012-2525-1&rft_dat=%3Cproquest_swepu%3E2660393511%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1013464305&rft_id=info:pmid/22476947&rfr_iscdi=true